These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25087504)

  • 1. The contraindications for a sentinel node biopsy in breast cancer are actually indications.
    Tjalma WA
    Surgeon; 2015 Feb; 13(1):59. PubMed ID: 25087504
    [No Abstract]   [Full Text] [Related]  

  • 2. Axillary sentinel lymph node biopsy: an overview.
    Rovera F; Frattini F; Marelli M; Corben AD; Dionigi G; Boni L; Dionigi R
    Int J Surg; 2008; 6 Suppl 1():S109-12. PubMed ID: 19131285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Status of sentinel node biopsy - response.
    Mann GB
    Surgeon; 2015 Feb; 13(1):60. PubMed ID: 25087503
    [No Abstract]   [Full Text] [Related]  

  • 4. Sentinel node biopsy in breast cancer revisited.
    Omair M; Al-Azawi D; Mann GB
    Surgeon; 2014 Jun; 12(3):158-65. PubMed ID: 24548701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can regional tattoos impact sentinel lymph node identification?
    Datrice N; Wirth G; Hsiang D; Butler J; Lane KT
    Am Surg; 2013 Mar; 79(3):331-2. PubMed ID: 23461966
    [No Abstract]   [Full Text] [Related]  

  • 6. Axillary lymph node dissection versus sentinel lymph node biopsy alone for early breast cancer with sentinel node metastasis: A meta-analysis.
    Li CZ; Zhang P; Li RW; Wu CT; Zhang XP; Zhu HC
    Eur J Surg Oncol; 2015 Aug; 41(8):958-66. PubMed ID: 26054706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary lymph node dissection for breast cancer: Primum non nocere.
    Lizarraga IM; Weigel RJ
    Eur J Surg Oncol; 2015 Aug; 41(8):955-7. PubMed ID: 26071786
    [No Abstract]   [Full Text] [Related]  

  • 8. Determinants of outcome in elderly patients with positive sentinel lymph nodes.
    Karam AK; Hsu M; Patil S; Stempel M; Traina TA; Ho AY; Cody HS; Morrow M; Gemignani ML
    Am J Surg; 2011 Jun; 201(6):734-40. PubMed ID: 20619395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Avoidance of axillary lymph node dissection in breast cancer patients with metastatic sentinel node - a pilot study].
    Černá M; Zedníková I; Ňaršanská A; Svoboda T; Hes O; Záhlava J; Hlaváčková M
    Rozhl Chir; 2015 Mar; 94(3):117-25. PubMed ID: 25754480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Identification of sentinel lymph nodes and mapping procedure of sentinel lymph nodes for breast cancer].
    Nohara T; Harada T; Tanigawa N
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():193-7. PubMed ID: 17682156
    [No Abstract]   [Full Text] [Related]  

  • 11. Sentinel lymph node biopsy: benefits and limitations.
    Morrow M
    Zentralbl Gynakol; 2003 Sep; 125(9):335-7. PubMed ID: 14569514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel node biopsy in breast cancer has a greater node positivity rate than axillary node sample: results from a retrospective analysis.
    Macaskill EJ; Dewar S; Purdie CA; Brauer K; Baker L; Brown DC
    Eur J Surg Oncol; 2012 Aug; 38(8):662-9. PubMed ID: 22592099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining axillary concordance rate for different injection locations in sentinel node mapping of breast cancer: how ambitious can we get?
    Sadeghi R; Asadi M; Treglia G; Zakavi SR; Fattahi A; Krag DN
    Breast Cancer Res Treat; 2014 Jul; 146(1):231-2. PubMed ID: 24878987
    [No Abstract]   [Full Text] [Related]  

  • 14. [Technical aspects of sentinel node biopsy].
    Hiratsuka M; Motomura K; Koyama H
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):275-80. PubMed ID: 14997768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dye-guided and radio-guided sentinel node biopsy in breast cancer].
    Imoto S; Ito H
    Nihon Geka Gakkai Zasshi; 2007 Sep; 108(5):281-3. PubMed ID: 17907460
    [No Abstract]   [Full Text] [Related]  

  • 16. The Biology Behind the American College of Surgeons Oncology Group Z0011 Trial.
    Stone K; Wheeler AJ
    JAMA Surg; 2015 Dec; 150(12):1148-9. PubMed ID: 26332793
    [No Abstract]   [Full Text] [Related]  

  • 17. INTRA OPERATIVE FROZEN EXAMINATION OF SENTINEL LYMPH NODE IN BREAST CANCER.
    Vohra LM; Gulzar R; Saleem O
    J Ayub Med Coll Abbottabad; 2015; 27(1):40-4. PubMed ID: 26182734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months.
    Babar M; Madani R; Jackson P; Layer GT; Kissin MW; Irvine TE
    Surgeon; 2016 Apr; 14(2):76-81. PubMed ID: 25444440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy.
    Kang YJ; Han W; Park S; You JY; Yi HW; Park S; Nam S; Kim JH; Yun KW; Kim HJ; Ahn SH; Park S; Lee JE; Lee ES; Noh DY; Lee JW
    Breast Cancer Res Treat; 2017 Nov; 166(2):473-480. PubMed ID: 28766131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes.
    Bonneau C; Hequet D; Estevez JP; Pouget N; Rouzier R
    Eur J Surg Oncol; 2015 Aug; 41(8):998-1004. PubMed ID: 25986854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.